Target intelligence / Profile preview

Bovine coronavirus spike protein (BCoV S protein)

Target
BCoV S protein
Molecular classification
Viral protein, Class I viral fusion protein, Receptor-binding protein
01

Overview

The Bovine coronavirus spike protein is a large trimeric glycoprotein present on the surface of the virus that plays a central role in viral infection by mediating host cell attachment and entry[1][2][4][7][8]. It is subdivided into S1 and S2 subunits; the S1 subunit contains the receptor-binding domain, which recognizes sugars (notably 5-N-acetyl-9-O-acetylneuraminic acid) on host cells, facilitating viral attachment[2][7][8]. The S2 subunit controls membrane fusion, allowing the virus to deliver its RNA genome into the host cell[1][4][5][10]. Structurally, the spike protein has a human galectin-like fold in its N-terminal domain, indicative of evolutionary adaptation from host lectins to accommodate viral receptor specificity[2][7]. The spike protein is a target for the host immune response, and its variability influences the scope of immunity and the effectiveness of diagnostics and therapeutics[8][9]. The spike protein is a major determinant of host range and pathogenicity, and mutations in its receptor-binding domain drive viral evolution and cross-species transmission[8].

Other names
BCoV S proteinSpike glycoproteinS proteinSurface glycoprotein
02

Mechanism of action

Inhibition of viral entry (by blocking spike protein-receptor interaction or fusion process); Neutralization by antibodies binding to epitopes in S1 or S2

03

Biological functions

Mediates viral entry into host cells via receptor binding and membrane fusionHost cell attachment (via sugar or protein receptor binding)Target for neutralizing antibodies
04

Disease associations

Infection (critical for the infection process by Bovine coronavirus, which causes diseases in cattle, including diarrhea, respiratory illness, and winter dysentery)May influence cross-species transmission due to receptor binding domain mutations
05

Safety considerations

Antigenic drift and escape mutations in the spike protein, which can reduce vaccine or antibody efficacyCross-reactivity with host proteins due to evolutionary acquisition of host-like folds (galectin fold)Difficulty targeting conserved epitopes due to high spike protein variability
06

Interacting drugs

Monoclonal antibodies (experimental)

2 more in the full profile.

07

Biomarkers

Presence of BCoV S protein or anti-spike antibodies in diagnostic assays for BCoV infection

Beyond the preview

Go deeper on Bovine coronavirus spike protein (BCoV S protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bovine coronavirus spike protein (BCoV S protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call